| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |